Novartis’s Ianalumab Meets Key Goal in Late-Stage Trials for Autoimmune Disease

Lung cancer rates seem low in sub-Saharan Africa, but doctors warn this underestimates the true impact of the disease in the region.

Editor’s Note: Understanding the real prevalence of lung cancer is crucial for improving healthcare responses and awareness in sub-Saharan Africa.

A charity warns that many men diagnosed with low-risk prostate cancer are receiving unnecessary treatments that could lead to serious side effects. Instead, monitoring options could be a better choice.

Editor’s Note: This story highlights an important conversation about the balance between effective cancer treatment and the risks of over-treatment, which can significantly impact patients' quality of life.

This health care roundup offers insights on major players like Novartis, Eli Lilly, and Dexcom, highlighting current market trends and news.

Editor’s Note: Staying updated on major health care companies helps investors and consumers understand market dynamics and potential impacts on treatment and innovation.

More babies are being introduced to meat-heavy diets, munching on items like lamb and pork rinds. Experts are worried about the nutritional implications of this trend.

Editor’s Note: This story highlights a controversial dietary trend for young children, raising questions about their health and nutrition as parents explore unconventional feeding practices.

This article explores the safety of melatonin as a sleep aid and discusses the controversial practice of eating placenta, weighing potential benefits and risks.

Editor’s Note: Understanding sleep aids and dietary choices like placentophagy is important for making informed health decisions that impact wellbeing.